Monte Rosa Therapeutics (GLUE) Price to FCF (2024 - 2025)
Monte Rosa Therapeutics' (GLUE) Price to FCF came in at 4.21 for Q3 2025, down 72.9% from the prior quarter.
Analysis
Monte Rosa Therapeutics (GLUE) Price to FCF (2024 - 2025) Analysis & Trends
For FY2024, Monte Rosa Therapeutics' Price to FCF stood at 11.23.
- According to Business Quant data, Price to FCF for the three prior quarters was 15.54 (Q2 2025), 12.51 (Q1 2025) and 11.23 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Monte Rosa Therapeutics | 894.88 Mn | 306.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.21 |
| Jun 30, 2025 | 15.54 |
| Mar 31, 2025 | 12.51 |
| Dec 31, 2024 | 11.23 |
API Access
Monte Rosa Therapeutics Price to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-fcf&ticker=GLUE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-fcf", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-fcf&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();